Jazz Pharmaceuticals (JAZZ) Construction in Progress (2010 - 2016)

Jazz Pharmaceuticals has reported Construction in Progress for 7 years, with the latest figure at $66.2 million in Q1 2016.

• For the quarter ending Q1 2016, Construction in Progress rose 33.85% year-over-year to $66.2 million; the trailing twelve-month figure through Mar 2016 stood at $66.2 million (up 33.85% YoY), and the FY2015 full-year result was $63.0 million, up 69.63% from the prior year.
• Construction in Progress for Q1 2016 stood at $66.2 million, up from $63.0 million in the prior quarter.
• The five-year high for Construction in Progress was $66.2 million in Q1 2016, with the low at $148000.0 in Q1 2012.
• Average Construction in Progress over 5 years is $24.0 million, with a median of $10.6 million recorded in 2014.
• Year-over-year, Construction in Progress soared 1239.19% in 2013 and soared 33.85% in 2016.
• Tracing JAZZ's Construction in Progress over 5 years: stood at $1.1 million in 2012, then soared by 286.61% to $4.4 million in 2013, then soared by 746.51% to $37.1 million in 2014, then surged by 69.63% to $63.0 million in 2015, then advanced by 5.04% to $66.2 million in 2016.
• The last three Construction in Progress figures came in at $66.2 million (Q1 2016), $63.0 million (Q4 2015), and $61.1 million (Q3 2015), per Business Quant data.

Peer Comparison